CL King Upgrades IDEXX Laboratories (IDXX) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $553.48 -0.8%
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Join SI Premium – FREE
CL King upgraded IDEXX Laboratories (NASDAQ: IDXX) from Neutral to Buy with a price target of $200.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $164.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Upgrades IGM Financial Inc (IGM:CN) (IGIFF) to Outperform
- Barclays Upgrades Standard Chartered Plc. (STAN:LN) (SCBFF) to Overweight
- Clear Street Upgrades Runway Growth Finance Corp. (RWAY) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
CL KingSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
